Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lyra Therapeutics, Inc. | 518,547 | reported | 06 Jan 2026 | tx 8+979,605−1,453 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2026 | SALE | Lyra Therapeutics, Inc. | 769 | 3.36 USD | |
| 10 Jul 2025 | SALE | Lyra Therapeutics, Inc. | 684 | 8.91 USD | |
| 08 Jan 2025 | GRANT_AWARD | Lyra Therapeutics, Inc. | 420,000 | 0.00 USD | |
| 16 Oct 2024 | GRANT_AWARD | Lyra Therapeutics, Inc. | 100,000 | 0.00 USD | |
| 30 Jan 2024 | GRANT_AWARD | Lyra Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 31 Jan 2023 | GRANT_AWARD | Lyra Therapeutics, Inc. | 140,000 | 0.00 USD | deriv |
| 12 Feb 2022 | GRANT_AWARD | Lyra Therapeutics, Inc. | 15,605 | 0.00 USD | deriv |
| 13 Sept 2021 | GRANT_AWARD | Lyra Therapeutics, Inc. | 104,000 | 0.00 USD | deriv |